Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Double-blind Study of Redasemtide (S-005151) in Acute Ischemic Stroke
jRCT2080224879Phase 2Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Sep 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ischemic stroke comparing Redasemtide IV with Placebo IV (2 arms). Started Sep 2019; status: completed.
02
Drugs
redasemtide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on jRCT2080224879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224879.